Evidence map›Paper›PMID 41647457›Full record

ReviewAvicenna journal of phytomedicine2026

Therapeutic potential of polyphenols in managing thalassemia: A comprehensive review.

Sajjad Jamali, Behzad Jamali, Marjan Golabi, Mehdi Rostami, Zahra Yousefi, Reza Dabbaghipour, Nahid Eskandari, Behrooz Ghezelbash, Sercan Karav, Amirhossein Sahebkar

Abstract readReview
In one paragraph

Review in Avicenna journal of phytomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sajjad JamaliDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Behzad JamaliDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Marjan GolabiDepartment of Medical Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan-Iran.
Mehdi RostamiDepartment of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Zahra YousefiSchool of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran.
Reza DabbaghipourDepartment of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Nahid EskandariDepartment of Medical Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan-Iran.
Behrooz GhezelbashDepartment of Medical Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan-Iran.
Sercan KaravDepartment of Molecular Biology and Genetics, Canakkale Onsekiz Mart University, Canakkale 17100, Turkey.
Amirhossein SahebkarApplied Biomedical Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to review the potential effects of polyphenols on iron overload and inflammation in patients with β-thalassemia. Materials and Methods: A literature search in electronic databases was carried out to identify studies exploring the therapeutic effects of flavonoids in thalassemia. Results: Patients with thalassemia suffer from excess iron in their bodies. In these patients, splenectomy is usually performed as an effective method to reduce the iron load and the need for blood transfusion. However, since the removal of the spleen in these patients to reduce the excess iron load is faced with serious side effects, it has been suggested to harness iron-chelators. Dietary polyphenols and polyphenol-rich products such as quercetin, curcumin, and silymarin prevent iron overload by reducing the serum levels of iron and ferritin. Polyphenols also reduce inflammation and oxidative stress by reducing tumor necrosis factor-α, C-reactive protein and malondialdehyde, and increasing total antioxidant capacity. Conclusion: The iron-chelating capacity of polyphenols and flavonoids which may have fewer side effects in patients with thalassemia, has garnered significant attention and holds a promise for therapeutic purposes.

Indexed as

CurcuminPolyphenolic compoundsQuercetinSilymarinβ-thalassemiam

Identifiers

PMID41647457
PMCPMC12872065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.